HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more DAY TRADING STRATEGIES: A Detailed Beginner’s Guide with Basic and Advanced Trading Strategies to Achieve Excellent Results and Become A Successful Trader with A... Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day – April 21, 2025 Mega Returns: Profit from Maximum Pessimism Tesla Q1 Preview: Expecting Near Record Revenues Prices to Weaken, Buyers Get Better Bargains Dividend Investing 102: Picking the Right Dividend Stocks (Massive Passive Income Books Book 137) LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
